Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
The Journal of Allergy and Clinical Immunology
|
February 20, 2021
Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma
Natasha A Winter, Ling Qin, Peter G Gibson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 16, 2020
Relationship of sputum mast cells with clinical and inflammatory characteristics of asthma
Michael Fricker, Ling Qin, Natalie Niessen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 22, 2025
Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab
Yuto Hamada, Dennis Thomas, Vanessa M McDonald, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 17, 2020
A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD
Katherine J Baines, Netsanet A Negewo, Peter G Gibson, et al.
Nature Communications
|
April 10, 2015
Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Paul S Baxter, Karen F S Bell, Philip Hasel, et al.
Nature Communications
|
September 12, 2017
Corrigendum: Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Paul S Baxter, Karen F S Bell, Philip Hasel, et al.
Respirology (Carlton, Vic.)
|
December 7, 2019
Sputum transcriptomics implicates increased p38 signalling activity in severe asthma
Katherine J Baines, Michael Fricker, Vanessa M McDonald, et al.
Biochemistry
|
July 9, 2003
In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand
Dirk Beher, Michael Fricker, Alan Nadin, et al.
The European Respiratory Journal
|
October 14, 2024
Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma
Yuto Hamada, Dennis Thomas, Erin S Harvey, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 8, 2024
Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
Yuto Hamada, Peter G Gibson, Erin S Harvey, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
The Journal of Allergy and Clinical Immunology
|
February 20, 2021
Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma
Natasha A Winter, Ling Qin, Peter G Gibson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 16, 2020
Relationship of sputum mast cells with clinical and inflammatory characteristics of asthma
Michael Fricker, Ling Qin, Natalie Niessen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 22, 2025
Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab
Yuto Hamada, Dennis Thomas, Vanessa M McDonald, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 17, 2020
A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD
Katherine J Baines, Netsanet A Negewo, Peter G Gibson, et al.
Nature Communications
|
April 10, 2015
Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Paul S Baxter, Karen F S Bell, Philip Hasel, et al.
Nature Communications
|
September 12, 2017
Corrigendum: Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Paul S Baxter, Karen F S Bell, Philip Hasel, et al.
Respirology (Carlton, Vic.)
|
December 7, 2019
Sputum transcriptomics implicates increased p38 signalling activity in severe asthma
Katherine J Baines, Michael Fricker, Vanessa M McDonald, et al.
Biochemistry
|
July 9, 2003
In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand
Dirk Beher, Michael Fricker, Alan Nadin, et al.
The European Respiratory Journal
|
October 14, 2024
Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma
Yuto Hamada, Dennis Thomas, Erin S Harvey, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 8, 2024
Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
Yuto Hamada, Peter G Gibson, Erin S Harvey, et al.
Page
of 6